Serac Healthcare is a clinical-stage radiopharmaceutical company revolutionising inflammatory disease diagnostics through precision molecular imaging technology. In our lead indication, endometriosis, our late-stage imaging agent 99mTc-maraciclatide is poised to address a critical diagnostic challenge, transforming patient care and outcomes, with definitive and timely diagnosis of early-stage endometriosis.